Saturday, July 11, 2026

pharma · Apnea of Prematurity · Safety and Pharmacokinetics

BELPHARMA

BELPHARMA clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Luxembourg, LU HQ
2011 Founded
16 Employees
EMA registrant Type
Company details
Status
Public
HQ
Luxembourg, LU
Founded
2011
Employees
16
Programs
3
Drugs
2
Patents
0
Intelligence · Clinical Programs

BELPHARMA projects

2 ClinicalTrials.gov programs sponsored by BELPHARMA.

BELPHARMA has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. NPC-22

    Belpharma s.a.

    Healthy Adult Subjects

    phase 1 small molecule completed

    1 trial
  2. NPC-22

    Belpharma s.a.

    Safety and Pharmacokinetics

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does BELPHARMA have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.